SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Net sales declined -9.46%  to  Rs. 44660.70 million from Rs. 49328.80 millions.Net Profit of the company move down -62.38% to Rs. 3806.40  millions from Rs. 10118.00 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 11123.00 millions from 14986.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 44660.70 49328.80 -9.46 44660.70 49328.80 -9.46 208121.40 155859.80 33.53
Other Income 1635.40 1762.10 -7.19 1635.40 1762.10 -7.19 3292.90 11968.80 -72.49
PBIDT 11123.00 14986.50 -25.78 11123.00 14986.50 -25.78 67518.90 38654.40 74.67
Interest 1579.40 870.70 81.39 1579.40 870.70 81.39 4721.80 3881.00 21.66
PBDT 8051.50 14115.80 -42.96 8051.50 14115.80 -42.96 33419.20 16568.10 101.71
Depreciation 4152.70 3745.00 10.89 4152.70 3745.00 10.89 16008.70 13499.50 18.59
PBT 3898.80 10370.80 -62.41 3898.80 10370.80 -62.41 17410.50 3068.60 467.38
TAX 92.40 252.80 -63.45 92.40 252.80 -63.45 503.30 4068.50 -87.63
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3806.40 10118.00 -62.38 3806.40 10118.00 -62.38 16907.20 -999.90 -1790.89
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 24.91 30.38 -18.02 24.91 30.38 -18.02 32.44 24.80 30.81

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×